Figure 5.
Expression levels of serum miR-199a/b-3p in patients with HCC staged as BCLC A, B, or C, and healthy individuals were significantly different (0.70±0.64 vs 1.07±1.42 vs 1.31±1.14 vs 2.50±2.16, P<0.001).
Notes: Higher serum miR-199a/b-3p expression level correlated with advanced BCLC stage. The results were analyzed with unpaired t-test.
Abbreviations: BCLC, Barcelona Clinic Liver Cancer; HCC, hepatocellular carcinoma; miR-199a/b-3p, microRNA-199a/b-3p.